Which are the causes of Palmoplantar Keratoderma?

TL;DR: Palmoplantar keratoderma (PPK) is a diverse group of skin disorders primarily caused by genetic mutations that disrupt the production of keratin, the protein responsible for skin strength. While some forms are inherited, others are acquired through environmental triggers, systemic diseases, or metabolic conditions, making the etiology highly variable depending on the specific subtype.

What causes Palmoplantar Keratoderma?

The primary cause of Palmoplantar Keratoderma is a disruption in the formation of the skin’s outer layer on the palms and soles. In hereditary forms, the body’s "instruction manual"—our DNA—contains mutations in genes responsible for creating keratin or associated proteins. Think of these genes like blueprints for a brick wall; if the blueprints are faulty, the resulting wall (your skin) becomes abnormally thick and calloused.

Is Palmoplantar Keratoderma hereditary or acquired?

Palmoplantar keratoderma can be classified into two main categories: hereditary and acquired. Hereditary forms are present from birth or early childhood and are passed through families via autosomal dominant or recessive patterns. In contrast, acquired Palmoplantar keratoderma develops later in life and is often linked to external factors or underlying health issues rather than a direct genetic inheritance.

What are the common triggers and risk factors?

While the genetic cause is the "blueprint" error, environmental and systemic factors can act as triggers or risk factors that worsen the condition. For those with acquired Palmoplantar keratoderma, common associations include:

• Chronic friction: Repetitive pressure or trauma to the hands and feet.


• Systemic diseases: Malignancies, particularly internal cancers, which may manifest as paraneoplastic keratoderma.


• Infections: Chronic fungal or viral infections that stimulate abnormal skin cell growth.


• Metabolic conditions: Thyroid dysfunction or nutritional deficiencies.


• Medications: Certain drug therapies can induce keratoderma as a side effect.

How is current research improving our understanding?

Researchers are currently using advanced genetic sequencing to identify specific mutations associated with the many subtypes of Palmoplantar keratoderma. By mapping these, scientists hope to develop targeted therapies that address the specific molecular pathway—such as the Wnt signaling pathway—rather than just treating the symptoms topically. Currently, 12 individuals have shared their unique experiences with Palmoplantar keratoderma on DiseaseMaps.org, providing valuable data that helps clinicians better understand the lived reality of these genetic and acquired mechanisms.

Next steps

• Consult a board-certified dermatologist for a skin biopsy or genetic testing to determine your specific subtype.


• Keep a detailed log of your symptoms and potential triggers to share with your medical team.


• Join the DiseaseMaps.org community to connect with others navigating the complexities of Palmoplantar keratoderma.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Palmoplantar keratoderma.


• Orphanet: Rare diseases database for hereditary palmoplantar keratodermas.


• OMIM (Online Mendelian Inheritance in Man): Comprehensive gene-phenotype data for keratodermas.


• Journal of the American Academy of Dermatology: Clinical reviews on the classification of palmoplantar keratodermas.